Kingymab: A Breakthrough in Immunotherapy
Introduction to Kingymab Kingymab is a pioneering monoclonal antibody used in the field of immunotherapy. It represents a significant advancement in cancer treatment, designed to harness the body’s immune system to identify and destroy cancer cells. Monoclonal antibodies like Kingymab are engineer to target specific antigens present on the surface of cancer cells, thereby enhancing…